(Q34187276)

31 July 2017

1 reference

title

Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition (English)

1 reference

bronchopulmonary dysplasia

31 July 2017

0 references

1 reference

1 reference

Eduardo Bancalari

1

1 reference

31 July 2017

Nelson Claure

series ordinal

2

1 reference

31 July 2017

Ilene R S Sosenko

series ordinal

3

1 reference

31 July 2017

publication date

1 February 2003

1 reference

Seminars in Fetal and Neonatal Medicine

31 July 2017

published in

1 reference

31 July 2017

volume

8

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

63-71

1 reference

Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Multivariate assessment of traditional risk factors for chronic lung disease in very low birth weight neonates

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Tracheal lavage and plasma fibronectin: relationship to respiratory distress syndrome and development of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Role of ureaplasma urealyticum in lung disease of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

The role of inflammation in the pathogenesis of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Potential role of eicosanoids and PAF in the pathophysiology of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Persistent elastase/proteinase inhibitor imbalance during prolonged ventilation of infants with bronchopulmonary dysplasia: evidence for the role of nosocomial infections

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Secretory leukocyte protease inhibitor and lung inflammation in developing bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Bronchopulmonary dysplasia: possible relationship to pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Control of water balance in infants with bronchopulmonary dysplasia: role of endogenous vasopressin

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Early closure of the patent ductus arteriosus in very low-birth-weight infants: a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Maximum diuresis--a factor in predicting recovery from respiratory distress syndrome and the development of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Fluid restriction for preventing bronchopulmonary dysplasia? Reduced fluid intake during the first weeks of life improves the outcome of low-birth-weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Lung compliance in newborns with patent ductus arteriosus before and after surgical ligation

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Effects of low protein diets or feed restriction on rat lung glutathione and oxygen toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Early prediction of chronic lung disease by pulmonary function testing

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Serial determination of pulmonary function in infants with chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Airway reactivity as determined by a cold air challenge in infants with bronchopulmonary dysplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Links between early adrenal function and respiratory outcome in preterm infants: airway inflammation and patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Closure of Patent Ductus arteriosus Decreases Pulmonary Myeloperoxidase in Premature Infants with Respiratory Distress Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Increased platelet activating factor in the tracheal aspirates from neonates with patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Pulmonary surfactant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g.

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Bronchopulmonary dysplasia: Clinical presentation

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

Variability in the use of supplemental oxygen for bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1084-2756%2802%2900192-6

7 January 2021

10.1016/S1084-2756(02)00192-6

Identifiers

DOI

1 reference

31 July 2017

1 reference